000 | 01533nam a22003497a 4500 | ||
---|---|---|---|
008 | 240723s20242024 xxu||||| |||| 00| 0 eng d | ||
022 | _a2405-8440 | ||
024 | _aPMC11002677 [pmc] | ||
024 | _aS2405-8440(24)04926-0 [pii] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a38596017 | ||
245 | _aCase report: Antidromic atrioventricular reentrant tachycardia and underlying Ebstein anomaly. | ||
251 | _aHeliyon. 10(7):e28895, 2024 Apr 15. | ||
252 | _aHeliyon. 10(7):e28895, 2024 Apr 15. | ||
253 | _aHeliyon | ||
260 | _c2024 | ||
260 | _p2024 Apr 15 | ||
260 | _fFY2024 | ||
265 | _sepublish | ||
265 | _tPubMed-not-MEDLINE | ||
520 | _aMultiple accessory pathways (APs) can develop in patients with Ebstein anomaly. Rarely, these APs can participate in antidromic atrioventricular reentrant tachycardia (AVRT) which can be life-threatening and requires unique considerations for acute management and ultimate ablation. These considerations are discussed herein. Copyright Published by Elsevier Ltd. | ||
546 | _aEnglish | ||
650 | _zAutomated | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aElectrophysiology | ||
657 | _aCase Reports | ||
700 |
_aThomaides, Athanasios _bMWHC |
||
700 |
_aTowheed, Arooge _bMWHC |
||
790 | _aNazari MA, Dapas N, Pacak K, Zhuang Z, Rosenblum JS, Jha A, Towheed A, Haigney MC, Thomaides A, Srichai MB | ||
856 |
_uhttps://dx.doi.org/10.1016/j.heliyon.2024.e28895 _zhttps://dx.doi.org/10.1016/j.heliyon.2024.e28895 |
||
942 |
_cART _dArticle |
||
999 |
_c14239 _d14239 |